Jerome Horwitz

Source: Wikipedia, the free encyclopedia.

Jerome Phillip Horwitz (January 16, 1919 – September 6, 2012)

American scientist; his affiliations included the Barbara Ann Karmanos Cancer Institute, the Wayne State University School of Medicine
and the Michigan Cancer Foundation.

Background

Horwitz was a

He earned his bachelor's and master's degrees in chemistry from the

University of Detroit; his doctorate in chemistry came from the University of Michigan. He completed his post-doctoral training at Northwestern University and the University of Michigan[4]

Clinical breakthroughs

In 1964, while conducting research for the

reverse-transcriptase inhibitors used in the treatment of HIV patients.[6]

Also during 1964, he published the first production and demonstration of X-gal as a chromogenic substrate.[7]

After synthesizing AZT, Horwitz went on to create many successful treatments for cancer and other diseases. At the time of his most recent findings, Horwitz was working for the Michigan Cancer Foundation with a

federal grant from the National Institutes of Health
; he retired in 2005.

Of further note

Sources

References

  1. ^ Vitello, Paul (21 September 2012). "Jerome Horwitz, AZT Creator, Dies at 93". The New York Times.
  2. ^ Emily Langer (September 23, 2012). "Researcher Jerome P. Horwitz, 93, created AZT, the first approved treatment for HIV/AIDS". The Washington Post. Retrieved 2012-09-21.
  3. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2008-07-03. Retrieved 2009-10-24.{{cite web}}: CS1 maint: archived copy as title (link)
  4. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2012-07-21. Retrieved 2009-10-28.{{cite web}}: CS1 maint: archived copy as title (link)
  5. ^ [1] Archived November 8, 2007, at the Wayback Machine
  6. ^ "Jerome Horwitz". The Daily Telegraph. London. September 30, 2012.
  7. PMID 14221156
    .
  8. ^ "I am alive today (history of an AIDS drug) - documentary film". Detourshenry.eu. Retrieved 2012-09-21.
  9. OCLC 854896885
    .